{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T17:43:52Z","timestamp":1789494232960,"version":"build-2803163510"},"reference-count":145,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2013,2,1]],"date-time":"2013-02-01T00:00:00Z","timestamp":1359676800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Nutrition"],"published-print":{"date-parts":[[2013,2]]},"DOI":"10.1016\/j.nut.2012.06.002","type":"journal-article","created":{"date-parts":[[2012,9,28]],"date-time":"2012-09-28T01:02:29Z","timestamp":1348794149000},"page":"370-378","source":"Crossref","is-referenced-by-count":48,"title":["Liver dysfunction and its nutritional implications in heart failure"],"prefix":"10.1016","volume":"29","author":[{"given":"Miroslava","family":"Valentov\u00e1","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephan","family":"von Haehling","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wolfram","family":"Doehner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J\u00e1n","family":"Mur\u00edn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefan D.","family":"Anker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anja","family":"Sandek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.nut.2012.06.002_bib1","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1097\/MED.0b013e3283469505","article-title":"Hormonal consequences and prognosis of chronic heart failure","volume":"18","author":"Attanasio","year":"2011","journal-title":"Curr Opin Endocrinol Diabetes Obes"},{"key":"10.1016\/j.nut.2012.06.002_bib2","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1093\/eurheartj\/ehl541","article-title":"Secretory sphingomyelinase is upregulated in chronic heart failure: a second messenger system of immune activation relates to body composition, muscular functional capacity, and peripheral blood flow","volume":"28","author":"Doehner","year":"2007","journal-title":"Eur Heart J"},{"key":"10.1016\/j.nut.2012.06.002_bib3","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1378\/chest.115.3.836","article-title":"Cardiac cachexia: a syndrome with impaired survival and immune and neuroendocrine activation","volume":"115","author":"Anker","year":"1999","journal-title":"Chest"},{"key":"10.1016\/j.nut.2012.06.002_bib4","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1136\/heart.84.4.431","article-title":"Apoptosis in the skeletal muscle of patients with heart failure: investigation of clinical and biochemical changes","volume":"84","author":"Vescovo","year":"2000","journal-title":"Heart"},{"key":"10.1016\/j.nut.2012.06.002_bib5","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1007\/s13539-010-0007-1","article-title":"Skeletal muscle wasting in cachexia and sarcopenia: molecular pathophysiology and impact of exercise training","volume":"1","author":"Lenk","year":"2010","journal-title":"J\u00a0Cachexia Sarcopenia Muscle"},{"key":"10.1016\/j.nut.2012.06.002_bib6","first-page":"45","article-title":"Increased proteasome activity in skeletal muscle of patients with chronic heart failure-a fluent transition to cachectic disease state?","volume":"1","author":"Szab\u00f3","year":"2010","journal-title":"J Cachexia Sarcopenia Muscle"},{"key":"10.1016\/j.nut.2012.06.002_bib7","doi-asserted-by":"crossref","first-page":"913029","DOI":"10.4061\/2011\/913029","article-title":"Cardiorenal syndrome: an unsolved clinical problem","volume":"2011","author":"Mart\u00ednez-Santos","year":"2011","journal-title":"Int J Nephrol"},{"key":"10.1016\/j.nut.2012.06.002_bib8","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1161\/CIRCULATIONAHA.105.580506","article-title":"Renal function as a predictor of outcome in a broad spectrum of patients with heart failure","volume":"113","author":"Hillege","year":"2006","journal-title":"Circulation"},{"key":"10.1016\/j.nut.2012.06.002_bib9","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1007\/s13539-011-0038-2","article-title":"Cardio-renal cachexia syndromes (CRCS): pathophysiological foundations of a vicious pathological circle","volume":"2","author":"Cicoira","year":"2011","journal-title":"J Cachexia Sarcopenia Muscle"},{"key":"10.1016\/j.nut.2012.06.002_bib10","doi-asserted-by":"crossref","DOI":"10.1016\/j.nut.2012.01.003","article-title":"Lung anabolic activity in patients with chronic heart failure: potential implications for clinical practice","author":"Aquilani","year":"2012","journal-title":"Nutrition"},{"key":"10.1016\/j.nut.2012.06.002_bib11","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1007\/s10741-011-9283-x","article-title":"Anemia in chronic heart failure: can we treat? What to treat?","volume":"17","author":"von Haehling","year":"2011","journal-title":"Heart Fail Rev"},{"key":"10.1016\/j.nut.2012.06.002_bib12","doi-asserted-by":"crossref","first-page":"1946","DOI":"10.1161\/CIRCULATIONAHA.108.784009","article-title":"Heart failure is a risk factor for orthopedic fracture","volume":"118","author":"van Diepen","year":"2008","journal-title":"Circulation"},{"key":"10.1016\/j.nut.2012.06.002_bib13","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s13539-010-0002-6","article-title":"Cachexia as a major underestimated and unmet medical need: facts and numbers","volume":"1","author":"von Haehling","year":"2010","journal-title":"J Cachexia Sarcopenia Muscle"},{"key":"10.1016\/j.nut.2012.06.002_bib14","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1007\/s13539-010-0013-3","article-title":"Diabetes mellitus, cachexia and obesity in heart failure: rationale and design of the Studies Investigating Co-morbidities Aggravating Heart Failure (SICA-HF)","volume":"1","author":"von Haehling","year":"2010","journal-title":"J Cachexia Sarcopenia Muscle"},{"key":"10.1016\/j.nut.2012.06.002_bib15","doi-asserted-by":"crossref","first-page":"22","DOI":"10.2174\/138920009787048374","article-title":"The gut and intestinal bacteria in chronic heart failure","volume":"10","author":"Sandek","year":"2009","journal-title":"Curr Drug Metab"},{"key":"10.1016\/j.nut.2012.06.002_bib16","doi-asserted-by":"crossref","first-page":"1561","DOI":"10.1016\/j.jacc.2007.07.016","article-title":"Altered intestinal function in patients with chronic heart failure","volume":"50","author":"Sandek","year":"2007","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.nut.2012.06.002_bib17","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.ijcard.2010.12.016","article-title":"Studies on bacterial endotoxin and intestinal absorption function in patients with chronic heart failure","volume":"157","author":"Sandek","year":"2012","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.nut.2012.06.002_bib18","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1097\/MCO.0b013e32832cdb0f","article-title":"Nutrition in heart failure: an update","volume":"12","author":"Sandek","year":"2009","journal-title":"Curr Opin Clin Nutr Metab Care"},{"key":"10.1016\/j.nut.2012.06.002_bib19","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/j.ijcard.2010.10.083","article-title":"The small intestine: a critical linkage in pathophysiology of cardiac cachexia","volume":"146","author":"Sandek","year":"2011","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.nut.2012.06.002_bib20","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1016\/j.ijcard.2007.11.103","article-title":"Collagen accumulation and dysfunctional mucosal barrier of the small intestine in patients with chronic heart failure","volume":"125","author":"Arutyunov","year":"2008","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.nut.2012.06.002_bib21","doi-asserted-by":"crossref","first-page":"1426","DOI":"10.1016\/S0002-9149(97)00159-8","article-title":"Elevated soluble CD14 receptors and altered cytokines in chronic heart failure","volume":"79","author":"Anker","year":"1997","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.nut.2012.06.002_bib22","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1056\/NEJM199007263230405","article-title":"Elevated circulating levels of tumor necrosis factor in severe chronic heart failure","volume":"323","author":"Levine","year":"1990","journal-title":"N Engl J Med"},{"key":"10.1016\/j.nut.2012.06.002_bib23","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1016\/0735-1097(95)00589-7","article-title":"Proinflammatory cytokine levels in patients with depressed left ventricular ejection fraction: a report from the Studies of Left Ventricular Dysfunction (SOLVD)","volume":"27","author":"Torre-Amione","year":"1996","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.nut.2012.06.002_bib24","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1111\/j.1527-5299.2006.05595.x","article-title":"Inflammatory biomarkers in heart failure","volume":"12","author":"Petersen","year":"2006","journal-title":"Congest Heart Fail"},{"key":"10.1016\/j.nut.2012.06.002_bib25","doi-asserted-by":"crossref","first-page":"1226","DOI":"10.1016\/0002-8703(94)90040-X","article-title":"Levels of T-lymphocyte subpopulations, interleukin-1 beta, and soluble interleukin-2 receptor in acute myocardial infarction","volume":"127","author":"Blum","year":"1994","journal-title":"Am Heart J"},{"key":"10.1016\/j.nut.2012.06.002_bib26","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.ijcard.2007.05.061","article-title":"Inflammatory pathways in patients with heart failure and preserved ejection fraction","volume":"129","author":"Niethammer","year":"2008","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.nut.2012.06.002_bib27","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1067\/mhj.2000.107177","article-title":"Heart diseases affecting the liver and liver diseases affecting the heart","volume":"140","author":"Naschitz","year":"2000","journal-title":"Am Heart J"},{"key":"10.1016\/j.nut.2012.06.002_bib28","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1001\/archinte.1987.00370070041006","article-title":"Liver function abnormalities in chronic heart failure. Influence of systemic hemodynamics","volume":"147","author":"Kubo","year":"1987","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.nut.2012.06.002_bib29","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1093\/eurjhf\/hfn031","article-title":"Liver function abnormalities and outcome in patients with chronic heart failure: data from the Candesartan in Heart Failure: Assessment of Reduction in Mortality and Morbidity (CHARM) program","volume":"11","author":"Allen","year":"2009","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.nut.2012.06.002_bib30","doi-asserted-by":"crossref","first-page":"227","DOI":"10.20452\/pamw.138","article-title":"Effect of elevated bilirubin levels on the long-term outcome in patients with chronic heart failure due to hypertension","volume":"117","author":"Szygu\u0142a-Jurkiewicz","year":"2007","journal-title":"Pol Arch Med Wewn"},{"key":"10.1016\/j.nut.2012.06.002_bib31","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1097\/00000441-197303000-00001","article-title":"The liver in congestive heart failure: a review","volume":"265","author":"Dunn","year":"1973","journal-title":"Am J Med Sci"},{"key":"10.1016\/j.nut.2012.06.002_bib32","doi-asserted-by":"crossref","first-page":"1613","DOI":"10.1093\/oxfordjournals.eurheartj.a060785","article-title":"The importance of abnormalities of liver function tests in predicting mortality in chronic heart failure","volume":"16","author":"Batin","year":"1995","journal-title":"Eur Heart J"},{"key":"10.1016\/j.nut.2012.06.002_bib33","doi-asserted-by":"crossref","first-page":"1405","DOI":"10.1016\/S0002-9149(02)02886-2","article-title":"Type of liver dysfunction in heart failure and its relation to the severity of tricuspid regurgitation","volume":"90","author":"Lau","year":"2002","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.nut.2012.06.002_bib34","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1053\/jhep.2003.50062","article-title":"Cardiac hepatopathy: clinical, hemodynamic, and histologic characteristics and correlations","volume":"37","author":"Myers","year":"2003","journal-title":"Hepatology"},{"key":"10.1016\/j.nut.2012.06.002_bib35","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1001\/archpedi.1985.02140030062030","article-title":"Hepatic dysfunction and cardiovascular abnormalities. Occurrence in infants, children, and young adults","volume":"139","author":"Mace","year":"1985","journal-title":"Am J Dis Child"},{"key":"10.1016\/j.nut.2012.06.002_bib36","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/0002-9343(61)90093-6","article-title":"Alterations in indices of liver function in congestive heart failure with particular reference to serum enzymes","volume":"30","author":"Richman","year":"1961","journal-title":"Am J Med"},{"key":"10.1016\/j.nut.2012.06.002_bib37","doi-asserted-by":"crossref","first-page":"1268","DOI":"10.1016\/S0016-5085(77)80025-5","article-title":"Endotoxin and bacteria in portal blood","volume":"72","author":"Jacob","year":"1977","journal-title":"Gastroenterology"},{"key":"10.1016\/j.nut.2012.06.002_bib38","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1111\/j.1432-2277.2005.00122.x","article-title":"Cardiac hepatopathy before and after heart transplantation","volume":"18","author":"Dichtl","year":"2005","journal-title":"Transpl Int"},{"key":"10.1016\/j.nut.2012.06.002_bib39","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1080\/00365521.1976.12097199","article-title":"Portal venous and systemic endotoxaemia in patients without liver disease and systemic endotoxaemia in patients with cirrhosis","volume":"11","author":"Prytz","year":"1976","journal-title":"Scand J Gastroenterol"},{"key":"10.1016\/j.nut.2012.06.002_bib40","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1146\/annurev.immunol.021908.132629","article-title":"The liver as a lymphoid organ","volume":"27","author":"Crispe","year":"2009","journal-title":"Annu Rev Immunol"},{"key":"10.1016\/j.nut.2012.06.002_bib41","first-page":"56","article-title":"Time course of cellular distribution of endotoxin in liver, lungs and kidneys of rats","volume":"63","author":"Freudenberg","year":"1982","journal-title":"Br J Exp Pathol"},{"key":"10.1016\/j.nut.2012.06.002_bib42","doi-asserted-by":"crossref","first-page":"2133","DOI":"10.4049\/jimmunol.123.5.2133","article-title":"The clearance, tissue distribution, and cellular localization of intravenously injected lipopolysaccharide in rabbits","volume":"123","author":"Mathison","year":"1979","journal-title":"J Immunol"},{"key":"10.1016\/j.nut.2012.06.002_bib43","doi-asserted-by":"crossref","first-page":"1838","DOI":"10.1016\/S0140-6736(98)09286-1","article-title":"Endotoxin and immune activation in chronic heart failure: a prospective cohort study","volume":"353","author":"Niebauer","year":"1999","journal-title":"Lancet"},{"key":"10.1016\/j.nut.2012.06.002_bib44","doi-asserted-by":"crossref","first-page":"1226","DOI":"10.1016\/S0002-9149(02)02839-4","article-title":"Pathophysiologic quantities of endotoxin-induced tumor necrosis factor-alpha release in whole blood from patients with chronic heart failure","volume":"90","author":"Genth-Zotz","year":"2002","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.nut.2012.06.002_bib45","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1016\/S1388-9842(03)00104-1","article-title":"Invasive assessment of bacterial endotoxin and inflammatory cytokines in patients with acute heart failure","volume":"5","author":"Peschel","year":"2003","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.nut.2012.06.002_bib46","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/j.ejheart.2004.03.002","article-title":"Studies on intragastric PCO2 at rest and during exercise as a marker of intestinal perfusion in patients with chronic heart failure","volume":"6","author":"Krack","year":"2004","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.nut.2012.06.002_bib47","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1111\/j.1478-3231.2006.01342.x","article-title":"Role of Kupffer cells in host defense and liver disease","volume":"26","author":"Bilzer","year":"2006","journal-title":"Liver Int"},{"key":"10.1016\/j.nut.2012.06.002_bib48","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1053\/he.2000.5634","article-title":"Kupffer cell activation by lipopolysaccharide in rats: role for lipopolysaccharide binding protein and toll-like receptor 4","volume":"31","author":"Su","year":"2000","journal-title":"Hepatology"},{"key":"10.1016\/j.nut.2012.06.002_bib49","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1016\/0168-8278(95)80433-1","article-title":"Human Kupffer cells secrete IL-10 in response to lipopolysaccharide (LPS) challenge","volume":"22","author":"Knolle","year":"1995","journal-title":"J Hepatol"},{"key":"10.1016\/j.nut.2012.06.002_bib50","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1002\/hep.1840010516","article-title":"Endotoxin, reticuloendothelial function, and liver injury","volume":"1","author":"Nolan","year":"1981","journal-title":"Hepatology"},{"key":"10.1016\/j.nut.2012.06.002_bib51","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1002\/hep.1840200228","article-title":"The role of tumor necrosis factor-alpha in acute endotoxin-induced hepatotoxicity in ethanol-fed rats","volume":"20","author":"Hansen","year":"1994","journal-title":"Hepatology"},{"key":"10.1016\/j.nut.2012.06.002_bib52","doi-asserted-by":"crossref","first-page":"1352","DOI":"10.1016\/S0735-1097(98)00101-6","article-title":"Increased oxidative stress in patients with congestive heart failure","volume":"31","author":"Keith","year":"1998","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.nut.2012.06.002_bib53","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1097\/MAJ.0b013e3182249fcd","article-title":"Oxidative stress in heart failure: what are we missing?","volume":"342","author":"Sawyer","year":"2011","journal-title":"Am J Med Sci"},{"key":"10.1016\/j.nut.2012.06.002_bib54","doi-asserted-by":"crossref","first-page":"1436","DOI":"10.1002\/mnfr.201000012","article-title":"Effect of dietary selenium on the progression of heart failure in the ageing spontaneously hypertensive rat","volume":"54","author":"Lymbury","year":"2010","journal-title":"Mol Nutr Food Res"},{"key":"10.1016\/j.nut.2012.06.002_bib55","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1002\/mnfr.201000393","article-title":"Dietary selenium intake influences Cx43 dephosphorylation, TNF-\u03b1 expression and cardiac remodeling after reperfused infarction","volume":"55","author":"Tanguy","year":"2011","journal-title":"Mol Nutr Food Res"},{"key":"10.1016\/j.nut.2012.06.002_bib56","doi-asserted-by":"crossref","first-page":"259S","DOI":"10.1093\/ajcn\/57.2.259S","article-title":"The epidemiology of selenium deficiency in the etiological study of endemic diseases in China","volume":"57","author":"Ge","year":"1993","journal-title":"Am J Clin Nutr"},{"key":"10.1016\/j.nut.2012.06.002_bib57","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1146\/annurev.nutr.24.012003.132120","article-title":"Selenoprotein P: an extracellular protein with unique physical characteristics and a role in selenium homeostasis","volume":"25","author":"Burk","year":"2005","journal-title":"Annu Rev Nutr"},{"key":"10.1016\/j.nut.2012.06.002_bib58","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1007\/s10741-006-9188-2","article-title":"Selenium and antioxidant defenses as major mediators in the development of chronic heart failure","volume":"11","author":"de Lorgeril","year":"2006","journal-title":"Heart Fail Rev"},{"key":"10.1016\/j.nut.2012.06.002_bib59","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1016\/S1388-9842(01)00179-9","article-title":"Dietary and blood antioxidants in patients with chronic heart failure. Insights into the potential importance of selenium in heart failure","volume":"3","author":"de Lorgeril","year":"2001","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.nut.2012.06.002_bib60","doi-asserted-by":"crossref","first-page":"1872","DOI":"10.1093\/eurheartj\/ehq158","article-title":"Iron deficiency: an ominous sign in patients with systolic chronic heart failure","volume":"31","author":"Jankowska","year":"2010","journal-title":"Eur Heart J"},{"key":"10.1016\/j.nut.2012.06.002_bib61","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.jacc.2007.09.036","article-title":"Effect of intravenous iron sucrose on exercise tolerance in anemic and nonanemic patients with symptomatic chronic heart failure and iron deficiency FERRIC-HF: a randomized, controlled, observer-blinded trial","volume":"51","author":"Okonko","year":"2008","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.nut.2012.06.002_bib62","first-page":"461","article-title":"Role of iron in optimizing responses of anemic cancer patients to erythropoietin","volume":"13","author":"Glaspy","year":"1999","journal-title":"Oncology"},{"key":"10.1016\/j.nut.2012.06.002_bib63","doi-asserted-by":"crossref","first-page":"S2","DOI":"10.1046\/j.1523-1755.1999.055Suppl.69002.x","article-title":"Cellular iron metabolism","volume":"69","author":"Ponka","year":"1999","journal-title":"Kidney Int Suppl"},{"key":"10.1016\/j.nut.2012.06.002_bib64","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.tcb.2006.12.003","article-title":"Iron uptake and metabolism in the new millennium","volume":"17","author":"Dunn","year":"2007","journal-title":"Trends Cell Biol"},{"key":"10.1016\/j.nut.2012.06.002_bib65","doi-asserted-by":"crossref","first-page":"568S","DOI":"10.1093\/jn\/131.2.568S","article-title":"Iron biology in immune function, muscle metabolism and neuronal functioning","volume":"131","author":"Beard","year":"2001","journal-title":"J Nutr"},{"key":"10.1016\/j.nut.2012.06.002_bib66","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1093\/ajcn\/75.4.734","article-title":"Marginal iron deficiency without anemia impairs aerobic adaptation among previously untrained women","volume":"75","author":"Brownlie","year":"2002","journal-title":"Am J Clin Nutr"},{"key":"10.1016\/j.nut.2012.06.002_bib67","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1136\/bmj.326.7399.1124","article-title":"Iron supplementation for unexplained fatigue in non-anaemic women: double blind randomised placebo controlled trial","volume":"326","author":"Verdon","year":"2003","journal-title":"BMJ"},{"key":"10.1016\/j.nut.2012.06.002_bib68","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/S0005-2728(99)00088-2","article-title":"Iron-dependent changes in cellular energy metabolism: influence on citric acid cycle and oxidative phosphorylation","volume":"1413","author":"Oexle","year":"1999","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.nut.2012.06.002_bib69","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1097\/00062752-200407000-00004","article-title":"Hepcidin in iron metabolism","volume":"11","author":"Ganz","year":"2004","journal-title":"Curr Opin Hematol"},{"key":"10.1016\/j.nut.2012.06.002_bib70","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1146\/annurev.nutr.26.061505.111303","article-title":"Regulation of iron metabolism by hepcidin","volume":"26","author":"Nemeth","year":"2006","journal-title":"Annu Rev Nutr"},{"key":"10.1016\/j.nut.2012.06.002_bib71","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.cell.2010.06.028","article-title":"Two to tango: regulation of mammalian iron metabolism","volume":"142","author":"Hentze","year":"2010","journal-title":"Cell"},{"key":"10.1016\/j.nut.2012.06.002_bib72","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1002\/ajh.21902","article-title":"Hepcidin in anemia of chronic heart failure","volume":"86","author":"Divakaran","year":"2011","journal-title":"Am J Hematol"},{"key":"10.1016\/j.nut.2012.06.002_bib73","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1253\/circj.CJ-09-0663","article-title":"Iron regulatory hormone hepcidin decreases in chronic heart failure patients with anemia","volume":"74","author":"Matsumoto","year":"2010","journal-title":"Circ J"},{"key":"10.1016\/j.nut.2012.06.002_bib74","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1016\/j.numecd.2010.08.006","article-title":"Nutritional intake and oxidative stress in chronic heart failure","volume":"22","author":"Hughes","year":"2010","journal-title":"Nutr Metab Cardiovasc Dis"},{"key":"10.1016\/j.nut.2012.06.002_bib75","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1159\/000046713","article-title":"Safety aspects of iron in food","volume":"45","author":"Sch\u00fcmann","year":"2001","journal-title":"Ann Nutr Metab"},{"key":"10.1016\/j.nut.2012.06.002_bib76","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1016\/S0002-8223(21)07902-5","article-title":"Iron nutrition and absorption: dietary factors which impact iron bioavailability","volume":"88","author":"Monsen","year":"1988","journal-title":"J Am Diet Assoc"},{"key":"10.1016\/j.nut.2012.06.002_bib77","doi-asserted-by":"crossref","first-page":"1461S","DOI":"10.3945\/ajcn.2010.28674F","article-title":"Iron Bioavailability and Dietary Reference Values","volume":"91","author":"Hurrell","year":"2010","journal-title":"Am J Clin Nutr"},{"key":"10.1016\/j.nut.2012.06.002_bib78","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1016\/S0140-6736(81)92463-6","article-title":"Iron and the sex difference in heart disease risk","volume":"1","author":"Sullivan","year":"1981","journal-title":"Lancet"},{"key":"10.1016\/j.nut.2012.06.002_bib79","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1161\/01.CIR.86.3.803","article-title":"High stored iron levels are associated with excess risk of myocardial infarction in eastern Finnish men","volume":"86","author":"Salonen","year":"1992","journal-title":"Circulation"},{"key":"10.1016\/j.nut.2012.06.002_bib80","doi-asserted-by":"crossref","first-page":"823","DOI":"10.7326\/0003-4819-123-11-199512010-00002","article-title":"Mortality in patients with hemophilia: changes in a Dutch population from 1986 to 1992 and 1973 to 1986","volume":"123","author":"Triemstra","year":"1995","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.nut.2012.06.002_bib81","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.1097\/00004872-200208000-00013","article-title":"Increased serum ferritin is common in men with essential hypertension","volume":"20","author":"Piperno","year":"2002","journal-title":"J Hypertens"},{"key":"10.1016\/j.nut.2012.06.002_bib82","doi-asserted-by":"crossref","first-page":"3300","DOI":"10.1161\/01.CIR.96.10.3300","article-title":"Body iron stores and the risk of carotid atherosclerosis: prospective results from the Bruneck study","volume":"96","author":"Kiechl","year":"1997","journal-title":"Circulation"},{"key":"10.1016\/j.nut.2012.06.002_bib83","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1093\/clinchem\/48.4.601","article-title":"Body iron stores and coronary heart disease","volume":"48","author":"Ma","year":"2002","journal-title":"Clin Chem"},{"key":"10.1016\/j.nut.2012.06.002_bib84","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1093\/ajcn\/76.3.501","article-title":"Do body iron stores increase the risk of developing coronary heart disease?","volume":"76","author":"Sempos","year":"2002","journal-title":"Am J Clin Nutr"},{"key":"10.1016\/j.nut.2012.06.002_bib85","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1161\/01.CIR.99.7.852","article-title":"Coronary heart disease and iron status: meta-analyses of prospective studies","volume":"99","author":"Danesh","year":"1999","journal-title":"Circulation"},{"key":"10.1016\/j.nut.2012.06.002_bib86","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1161\/01.CIR.103.1.52","article-title":"Blood donations and risk of coronary heart disease in men","volume":"103","author":"Ascherio","year":"2001","journal-title":"Circulation"},{"key":"10.1016\/j.nut.2012.06.002_bib87","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1016\/S1047-2797(00)00068-5","article-title":"Serum ferritin and death from all causes and cardiovascular disease","volume":"10","author":"Sempos","year":"2000","journal-title":"Ann Epidemiol"},{"key":"10.1016\/j.nut.2012.06.002_bib88","doi-asserted-by":"crossref","first-page":"1942","DOI":"10.1161\/CIRCULATIONAHA.105.545350","article-title":"Non-transferrin-bound iron and risk of coronary heart disease in postmenopausal women","volume":"113","author":"van der A","year":"2006","journal-title":"Circulation"},{"key":"10.1016\/j.nut.2012.06.002_bib89","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1016\/j.numecd.2010.03.009","article-title":"Red meat consumption and risk of heart failure in male physicians","volume":"21","author":"Ashaye","year":"2011","journal-title":"Nutr Metab Cardiovasc Dis"},{"key":"10.1016\/j.nut.2012.06.002_bib90","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1093\/eurheartj\/ehi027","article-title":"Dietary haem iron and coronary heart disease in women","volume":"26","author":"van der A","year":"2005","journal-title":"Eur Heart J"},{"key":"10.1016\/j.nut.2012.06.002_bib91","doi-asserted-by":"crossref","first-page":"283","DOI":"10.3390\/nu3030283","article-title":"Iron, meat and health","volume":"3","author":"Geissler","year":"2011","journal-title":"Nutrients"},{"key":"10.1016\/j.nut.2012.06.002_bib92","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1001\/jama.297.6.603","article-title":"Reduction of iron stores and cardiovascular outcomes in patients with peripheral arterial disease: a randomized controlled trial","volume":"297","author":"Zacharski","year":"2007","journal-title":"JAMA"},{"key":"10.1016\/j.nut.2012.06.002_bib93","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1016\/j.ahj.2011.08.013","article-title":"Effect of controlled reduction of body iron stores on clinical outcomes in peripheral arterial disease","volume":"162","author":"Zacharski","year":"2011","journal-title":"Am Heart J"},{"key":"10.1016\/j.nut.2012.06.002_bib94","doi-asserted-by":"crossref","first-page":"2436","DOI":"10.1056\/NEJMoa0908355","article-title":"Ferric carboxymaltose in patients with heart failure and iron deficiency","volume":"361","author":"Anker","year":"2009","journal-title":"N Engl J Med"},{"key":"10.1016\/j.nut.2012.06.002_bib95","doi-asserted-by":"crossref","first-page":"1657","DOI":"10.1016\/j.jacc.2007.07.029","article-title":"Intravenous iron reduces NT-pro-brain natriuretic peptide in anemic patients with chronic heart failure and renal insufficiency","volume":"50","author":"Toblli","year":"2007","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.nut.2012.06.002_bib96","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1016\/j.jacc.2006.07.015","article-title":"Intravenous iron alone for the treatment of anemia in patients with chronic heart failure","volume":"48","author":"Bolger","year":"2006","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.nut.2012.06.002_bib97","first-page":"236","article-title":"Intravenous iron without erythropoietin for the treatment of iron deficiency anemia in patients with moderate to severe congestive heart failure and chronic kidney insufficiency","volume":"21","author":"Usmanov","year":"2008","journal-title":"J Nephrol"},{"key":"10.1016\/j.nut.2012.06.002_bib98","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1093\/eurjhf\/hfs017","article-title":"Iron supplementation for the treatment of chronic heart failure and iron deficiency: systematic review and meta-analysis","volume":"14","author":"Avni","year":"2012","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.nut.2012.06.002_bib99","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1186\/1471-2369-10-6","article-title":"The importance of iron in long-term survival of maintenance hemodialysis patients treated with epoetin-alfa and intravenous iron: analysis of 9.5 years of prospectively collected data","volume":"10","author":"Pollak","year":"2009","journal-title":"BMC Nephrol"},{"key":"10.1016\/j.nut.2012.06.002_bib100","doi-asserted-by":"crossref","first-page":"1623","DOI":"10.1097\/01.ASN.0000128009.69594.BE","article-title":"Administration of parenteral iron and mortality among hemodialysis patients","volume":"15","author":"Feldman","year":"2004","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.nut.2012.06.002_bib101","doi-asserted-by":"crossref","first-page":"3070","DOI":"10.1681\/ASN.2005040423","article-title":"Time-dependent associations between iron and mortality in hemodialysis patients","volume":"16","author":"Kalantar-Zadeh","year":"2005","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.nut.2012.06.002_bib102","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1161\/HYPERTENSIONAHA.110.159681","article-title":"Dietary iron restriction prevents hypertensive cardiovascular remodeling in Dahl salt-sensitive rats","volume":"57","author":"Naito","year":"2011","journal-title":"Hypertension"},{"key":"10.1016\/j.nut.2012.06.002_bib103","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1159\/000329951","article-title":"Atrial and vascular oxidative stress in patients with heart failure","volume":"27","author":"Rochette","year":"2011","journal-title":"Cell Physiol Biochem"},{"key":"10.1016\/j.nut.2012.06.002_bib104","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1161\/CIRCHEARTFAILURE.111.960906","article-title":"Iron deficiency in community-dwelling US adults with self-reported heart failure in the National Health and Nutrition Examination Survey III: prevalence and associations with anemia and inflammation","volume":"4","author":"Parikh","year":"2011","journal-title":"Circ Heart Fail"},{"key":"10.1016\/j.nut.2012.06.002_bib105","doi-asserted-by":"crossref","first-page":"1525","DOI":"10.1046\/j.1523-1755.2001.00976.x","article-title":"Increase in plasma esterified F2-isoprostanes following intravenous iron infusion in patients on hemodialysis","volume":"60","author":"Salahudeen","year":"2001","journal-title":"Kidney Int"},{"key":"10.1016\/j.nut.2012.06.002_bib106","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1186\/1471-2369-11-16","article-title":"Effect of different intravenous iron preparations on lymphocyte intracellular reactive oxygen species generation and subpopulation survival","volume":"11","author":"Gupta","year":"2010","journal-title":"BMC Nephrol"},{"key":"10.1016\/j.nut.2012.06.002_bib107","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1093\/oxfordjournals.ndt.a027405","article-title":"\u201cOversaturation\u201d of transferrin after intravenous ferric gluconate (Ferrlecit(R)) in haemodialysis patients","volume":"11","author":"Zanen","year":"1996","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.nut.2012.06.002_bib108","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1053\/ajkd.2002.36334","article-title":"Induction of protein oxidation by intravenous iron in hemodialysis patients: role of inflammation","volume":"40","author":"Tovbin","year":"2002","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.nut.2012.06.002_bib109","doi-asserted-by":"crossref","DOI":"10.5301\/jn.5000072","article-title":"The effect of different doses and types of intravenous iron on oxidative stress and inflammation in hemodialysis patients","author":"Kumbasar","year":"2012","journal-title":"J Nephrol"},{"key":"10.1016\/j.nut.2012.06.002_bib110","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1111\/j.1440-1797.2004.00262.x","article-title":"Oxidative stress from rapid versus slow intravenous iron replacement in haemodialysis patients","volume":"9","author":"Tiranathanagul","year":"2004","journal-title":"Nephrology"},{"key":"10.1016\/j.nut.2012.06.002_bib111","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1159\/000188510","article-title":"Evaluation of red blood cell lipoperoxidation in hemodialysed patients during erythropoietin therapy supplemented or not with iron","volume":"69","author":"Delmas-Beauvieux","year":"1995","journal-title":"Nephron"},{"key":"10.1016\/j.nut.2012.06.002_bib112","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1093\/ndt\/16.2.335","article-title":"Oxidative stress and haemodialysis: role of inflammation and duration of dialysis treatment","volume":"16","author":"Nguyen-Khoa","year":"2001","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.nut.2012.06.002_bib113","doi-asserted-by":"crossref","first-page":"1648","DOI":"10.1097\/01.ASN.0000130149.18412.56","article-title":"Non-transferrin\u2013bound iron in the serum of hemodialysis patients who receive ferric saccharate: no correlation to peroxide generation","volume":"15","author":"Scheiber-Mojdehkar","year":"2004","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.nut.2012.06.002_bib114","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1055\/s-0031-1296218","article-title":"Assessment of the extent of oxidative stress induced by intravenous ferumoxytol, ferric carboxymaltose, iron sucrose and iron dextran in a nonclinical model","volume":"61","author":"Toblli","year":"2011","journal-title":"Arzneimittelforschung"},{"key":"10.1016\/j.nut.2012.06.002_bib115","doi-asserted-by":"crossref","first-page":"66","DOI":"10.2174\/187152812798889358","article-title":"Comparison of oxidative stress and inflammation induced by different intravenous iron sucrose similar preparations in a rat model","volume":"11","author":"Toblli","year":"2012","journal-title":"Inflamm Allergy Drug Targets"},{"key":"10.1016\/j.nut.2012.06.002_bib116","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1016\/j.nut.2010.09.010","article-title":"Zinc restriction during different periods of life: influence in renal and cardiovascular diseases","volume":"27","author":"Tomat","year":"2011","journal-title":"Nutrition"},{"key":"10.1016\/j.nut.2012.06.002_bib117","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1016\/j.cardiores.2006.08.018","article-title":"Nutrition, metabolism, and the complex pathophysiology of cachexia in chronic heart failure","volume":"73","author":"von Haehling","year":"2007","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.nut.2012.06.002_bib118","doi-asserted-by":"crossref","first-page":"1337","DOI":"10.1089\/ars.2010.3275","article-title":"Selenium in human health and disease","volume":"14","author":"Fairweather-Tait","year":"2011","journal-title":"Antioxid Redox Signal"},{"key":"10.1016\/j.nut.2012.06.002_bib119","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.mrfmmm.2011.12.011","article-title":"Selenium and its role in the maintenance of genomic stability","volume":"733","author":"Ferguson","year":"2012","journal-title":"Mutat Res"},{"key":"10.1016\/j.nut.2012.06.002_bib120","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1093\/ajcn\/81.4.829","article-title":"Effectiveness of selenium supplements in a low-selenium area of China","volume":"81","author":"Xia","year":"2005","journal-title":"Am J Clin Nutr"},{"key":"10.1016\/j.nut.2012.06.002_bib121","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1016\/j.nut.2004.08.025","article-title":"Serum selenoprotein-P levels in patients with inflammatory bowel disease","volume":"21","author":"Andoh","year":"2005","journal-title":"Nutrition"},{"key":"10.1016\/j.nut.2012.06.002_bib122","doi-asserted-by":"crossref","first-page":"2238","DOI":"10.1093\/eurheartj\/ehi442","article-title":"The effect of micronutrient supplementation on quality-of-life and left ventricular function in elderly patients with chronic heart failure","volume":"26","author":"Witte","year":"2005","journal-title":"Eur Heart J"},{"key":"10.1016\/j.nut.2012.06.002_bib123","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1097\/MJT.0b013e3181d169db","article-title":"Drug therapy of heart failure: an immunologic view","volume":"18","author":"El Desoky","year":"2011","journal-title":"Am J Ther"},{"key":"10.1016\/j.nut.2012.06.002_bib124","first-page":"90","article-title":"Statins: a treatment option for chronic heart failure?","volume":"4","author":"von Haehling","year":"2004","journal-title":"Heart Fail Monit"},{"key":"10.1016\/j.nut.2012.06.002_bib125","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1093\/ajcn\/73.2.219","article-title":"A controlled clinical trial of vitamin E supplementation in patients with congestive heart failure","volume":"73","author":"Keith","year":"2001","journal-title":"Am J Clin Nutr"},{"key":"10.1016\/j.nut.2012.06.002_bib126","doi-asserted-by":"crossref","first-page":"347","DOI":"10.2459\/01.JCM.0000223257.09062.17","article-title":"Vitamin E increases the risk of developing heart failure after myocardial infarction: results from the GISSI-Prevenzione trial","volume":"7","author":"Marchioli","year":"2006","journal-title":"J Cardiovasc Med"},{"key":"10.1016\/j.nut.2012.06.002_bib127","doi-asserted-by":"crossref","first-page":"2182","DOI":"10.1161\/hc4301.098284","article-title":"Vitamin C inhibits endothelial cell apoptosis in congestive heart failure","volume":"104","author":"R\u00f6ssig","year":"2001","journal-title":"Circulation"},{"key":"10.1016\/j.nut.2012.06.002_bib128","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1016\/j.ahj.2007.07.005","article-title":"Vitamin C restores the contractile response to dobutamine and improves myocardial efficiency in patients with heart failure after anterior myocardial infarction","volume":"154","author":"Shinke","year":"2007","journal-title":"Am Heart J"},{"key":"10.1016\/j.nut.2012.06.002_bib129","doi-asserted-by":"crossref","first-page":"1240","DOI":"10.1161\/01.HYP.0000073581.74107.22","article-title":"Influence of vitamin C on baroreflex sensitivity in chronic heart failure","volume":"41","author":"Piccirillo","year":"2003","journal-title":"Hypertension"},{"key":"10.1016\/j.nut.2012.06.002_bib130","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1016\/S0140-6736(08)61239-8","article-title":"Effect of n-3 polyunsaturated fatty acids in patients with chronic heart failure (the GISSI-HF trial): a randomised, double-blind, placebo-controlled trial","volume":"372","author":"Tavazzi","year":"2008","journal-title":"Lancet"},{"key":"10.1016\/j.nut.2012.06.002_bib131","doi-asserted-by":"crossref","first-page":"915.e1","DOI":"10.1016\/j.ahj.2011.02.011","article-title":"Dose-dependent effects of omega-3-polyunsaturated fatty acids on systolic left ventricular function, endothelial function, and markers of inflammation in chronic heart failure of nonischemic origin: a double-blind, placebo-controlled, 3-arm study","volume":"161","author":"Moertl","year":"2011","journal-title":"Am Heart J"},{"key":"10.1016\/j.nut.2012.06.002_bib132","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1093\/eurjhf\/hfr023","article-title":"Cost-effectiveness of highly purified omega-3 polyunsaturated fatty acid ethyl esters in the treatment of chronic heart failure: results of Markov modelling in a UK setting","volume":"13","author":"Cowie","year":"2011","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.nut.2012.06.002_bib133","first-page":"45","article-title":"Effects of marine n-3 fatty acids on circulating levels of soluble adhesion molecules in patients with chronic heart failure","volume":"56","author":"Eschen","year":"2010","journal-title":"Cell Mol Biol"},{"key":"10.1016\/j.nut.2012.06.002_bib134","doi-asserted-by":"crossref","first-page":"1831","DOI":"10.1177\/147323000903700619","article-title":"Effects of n-3 polyunsaturated fatty acid therapy on plasma inflammatory markers and N-terminal pro-brain natriuretic peptide in elderly patients with chronic heart failure","volume":"37","author":"Zhao","year":"2009","journal-title":"J Int Med Res"},{"key":"10.1016\/j.nut.2012.06.002_bib135","doi-asserted-by":"crossref","first-page":"1600","DOI":"10.1016\/j.jacc.2006.05.073","article-title":"Enhanced baroreceptor control of the cardiovascular system by polyunsaturated fatty acids in heart failure patients","volume":"48","author":"Radaelli","year":"2006","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.nut.2012.06.002_bib136","first-page":"S8","article-title":"Effect of (n-3) polyunsaturated fatty acidson cytokine production and their biologic function","volume":"12","author":"Meydani","year":"1996","journal-title":"Nutrition"},{"key":"10.1016\/j.nut.2012.06.002_bib137","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1016\/j.healun.2006.03.005","article-title":"Fish oils produce anti-inflammatory effects and improve body weight in severe heart failure","volume":"25","author":"Mehra","year":"2006","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.nut.2012.06.002_bib138","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/S0014-5793(00)02351-6","article-title":"Eicosapentaenoic acid (EPA) induces Ca(2+)-independent activation and translocation of endothelial nitric oxide synthase and endothelium-dependent vasorelaxation","volume":"487","author":"Omura","year":"2001","journal-title":"FEBS Lett"},{"key":"10.1016\/j.nut.2012.06.002_bib139","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1016\/j.amjcard.2005.08.075","article-title":"Effects of dietary omega-3 fatty acid supplementation on endothelium-dependent vasodilation in patients with chronic heart failure","volume":"97","author":"Morgan","year":"2006","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.nut.2012.06.002_bib140","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/S0195-668X(02)00618-8","article-title":"Management of acute myocardial infarction in patients presenting with ST-segment elevation. The Task Force on the Management of Acute Myocardial Infarction of the European Society of Cardiology","volume":"24","author":"Van de Werf","year":"2003","journal-title":"Eur Heart J"},{"key":"10.1016\/j.nut.2012.06.002_bib141","doi-asserted-by":"crossref","first-page":"2747","DOI":"10.1161\/01.CIR.0000038493.65177.94","article-title":"Fish consumption, fish oil, omega-3 fatty acids, and cardiovascular disease","volume":"106","author":"Kris-Etherton","year":"2002","journal-title":"Circulation"},{"key":"10.1016\/j.nut.2012.06.002_bib142","doi-asserted-by":"crossref","first-page":"1787","DOI":"10.1093\/eurheartj\/ehs104","volume":"33","author":"McMurray","year":"2012","journal-title":"Eur Heart J"},{"key":"10.1016\/j.nut.2012.06.002_bib143","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1007\/s11897-010-0034-4","article-title":"Intravenous iron in heart failure: beyond targeting anemia","volume":"8","author":"Silverberg","year":"2011","journal-title":"Curr Heart Fail Rep"},{"key":"10.1016\/j.nut.2012.06.002_bib144","doi-asserted-by":"crossref","DOI":"10.1016\/j.ahj.2006.08.005","article-title":"Erythropoietin improves anemia exercise tolerance and renal function and reduces B-type natriuretic peptide and hospitalization in patients with heart failure and anemia","volume":"152","author":"Palazzuoli","year":"2006","journal-title":"Am Heart J"},{"key":"10.1016\/j.nut.2012.06.002_bib145","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1053\/j.ajkd.2008.05.033","article-title":"Intravenous versus oral iron supplementation for the treatment of anemia in CKD: systematic review and meta-analysis","volume":"52","author":"Rozen-Zvi","year":"2008","journal-title":"Am J Kidney Dis"}],"container-title":["Nutrition"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0899900712002596?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0899900712002596?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,4,9]],"date-time":"2025-04-09T17:28:41Z","timestamp":1744219721000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0899900712002596"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,2]]},"references-count":145,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2013,2]]}},"alternative-id":["S0899900712002596"],"URL":"https:\/\/doi.org\/10.1016\/j.nut.2012.06.002","relation":{},"ISSN":["0899-9007"],"issn-type":[{"value":"0899-9007","type":"print"}],"subject":[],"published":{"date-parts":[[2013,2]]}}}